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Abstract 
This present study was designed to determine the effect of pulmonary tuberculosis treatment for 2 months, 4 
months and 6 months on total protein, albumin, globulin, IgG and IgM in pulmonary tuberculosis infected 
participants in Anambra State, Nigeria. A total of 220 pulmonary tuberculosis infected subjects aged 18 – 60 
were recruited for the study. After informed consent and ethical approval, blood samples were collected for 
analysis. Serum proteins were assayed using biuret method. IgG and IgM were assayed using turbidimetric 
method. Tuberculosis diagnosis was also carried out using Ziehl Neelsen technique. The result showed that the 
mean ±SD concentration of total protein (g/dl), globulin (g/dl), IgG (mg/dl) and IgM (mg/dl) were significantly 
higher in tuberculosis infected participants compared (in each case) with the control subjects, 2 months, 4 
months and 6 months treatment subjects (P<0.05). The mean ±SD albumin concentration was significantly lower 
in tuberculosis infected participants compared in each case with the control subjects (P<0.05). The present study 
showed increase total protein, globulin, 1gG and 1gM in pulmonary tuberculosis infection. The serum 
concentration of these parameters returned to normal as patients undergo treatment. Therefore we recommend 
that total protein, albumin, globulin, 1gG and 1gM should be considered as one of the baseline test for 
tuberculosis infection.   
Keywords: Pulmonary tuberculosis, total protein, albumin, globulin, 1gG, 1gM. 
 
1. Introduction 
Pulmonary tuberculosis (PTB) is a common disease in developing countries. Efforts have been made to diagnose 
this group of patients presenting with complex immunological and biochemical abnormalities (Bradley et al, 
2003). Pulmonary tuberculosis spread through the air when people who have an active Mycobacterium 
tuberculosis infection cough, sneezes or spit (Bradley et al, 2003, Konstantinous 2010). It can also be gotten 
through eating meat infected with tuberculosis and drinking unpasteurized milk (Kumar et al, 2007). Most 
infection in humans result in an asymptomatic latent infection and about 1:10 latent infections eventually 
progresses to active diseases especially in immune compromised states like HIV (Kumar et al, 2007). 
Pulmonary tuberculosis infection is common in Nigeria at an incidence rate of 27 per 100,000 
populations. Tuberculosis accounts for 1.8 million deaths and is the world’s greatest infectious killer of man and 
the leading cause of death among people with HIV/AIDS (WHO 2009). The emergence of multiple drug 
resistant strains (MDR-TB) has also contributed to this new epidemic with from 2000 to 2004, 20% of 
tuberculosis cases being resistant to standard treatment (WHO 2009).  
Few studies have been reported on the effects of pulmonary tuberculosis on serum proteins and 
immunoglobulins  especially in Nigerian literature.  Biochemical abnormalities such as hypoalbuminaemia, 
hyperproteinaemia and hyperglobulinaemia have been reported in patients with pulmonary tuberculosis (Ferrara 
2006). It has been shown in previous studies that a high proportion of patients with tuberculosis has significantly 
increased levels of antibodies to Mycobacterium tuberculosis (Al- Omar et al, 2009). Increased levels of IgG 
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with low titers of IgM in patients with pulmonary tuberculosis have been reported (Geisberger et al, 2006).  
The objectives of this study are therefore to explore avenues to aid in the improved understanding of the disease 
entity. This will enhance the diagnosis and treatment of PTB infected persons by determining the effects of 
pulmonary tuberculosis treatment on some biochemical parameters in pulmonary tuberculosis infected 
participants. 
 
2. Materials and Methods 
2.1 subjects 
 A total of two hundred and twenty pulmonary tuberculosis infected patients aged 18 – 60 years were recruited 
for the study from the Direct Observation and Treatment (DOTS) centre of NAUTH, Nnewi based on sputum 
smear acid fast bacilli positive by Ziehl Neelsen stain. One hundred (100) subjects were in their pretreatment 
stage and 40 subjects each in their 2 months, 4 months and 6 month’s post treatment stages respectively. Eight 
(80) age and sex matched apparently healthy subjects who visits the hospital for medical check- up served as 
control. Ethical approval was obtained from the ethics committee of Nnamdi Aziikiwe University Teaching 
Hospital, Nnewi before embarking on the study. Informed consent was also obtained from the subjects.  
 
2.2 methods 
The TB positive subjects were identified based on sputum smear acid fast bacilli positive by Ziehl Neelsen stain 
technique which relies on the principle that M. tuberculosis is acid fast and stains red due to mycolic acids (fatty 
acids) in the cell wall which form a complex with carbol fucsin (an arylmethane dye) and cannot be removed by 
the acid in the decolorizing reagent (Cheesbrough 2000). A piece of clean stick was used to transfer and spread 
sputum materials evenly covering an area of about 15-20mm diameter on a slide. The smear was air dried and 
labeled.  
The slide with the smear uppermost was rapidly passed three times through the flame of a Bunsen 
burner and allowed to cool. The slide containing the smear was placed on a slide rack and the smear covered 
with carbol fuchsin stain. The stain was heated until vapour just begins to rise. The heated stain was allowed to 
remain on the slide for 5 minutes. The stain was washed off with clean water and then covered with 3% v/v acid 
alcohol for 5 minutes or until the smear is sufficiently decolorized, i.e. pale pink. The slide was washed off with 
clean water. The smear was covered with methylene blue stain for 1-2 minutes and then washed off with clean 
water. The back of the slide was wiped clean and placed in a draining rack for the smear to air-dry. The smear 
was examined microscopically using the 100 X oil immersion objective. Scanning of the smear was done 
systematically and when any definite red bacilli was seen, it was reported as AFB positive. Two mililiters of 
blood was collected from all the participants for the analysis of the parameters. Serum proteins were assayed 
using biuret method as described by Gornall et al, (1949). 1gG and 1gM were assayed by turbidimetric method 
as described by the manufacturer of the kit linear chemicals, Barcelona, Spain which relies on the principle that 
Anti-human IgG or IgM antibodies form insoluble complexes when mixed with samples containing IgG or IgM. 
The scattering light of the immuno-complexes depends on the IgG or IgM concentration in the patient sample 
and can be quantified by comparison from a calibrator of known IgG or IgM concentration. The reagent for the 
assay was pre-warmed to 37
0
C. Distilled water was used to zero the photometer at 540nm. Seven microlitres of 
the serum was mixed with 1.0ml of the reagent (R1) provided in the kit in a cuvette. The absorbance was 
recorded after 2 minutes. This procedure was performed on the different dilutions of the calibrator as described 
in the kit’s manual. The different absorbance value is plotted against the IgG or IgM concentration of each 
calibrator dilution. IgG or IgM concentration in the sample was calculated by interpolation of its absorbance 
value in the calibration curve. 
 
2.3 statistical methods 
Results generated in this study were tabulated using excel, statistical analysis was done using SPSS package. The 
variables were expressed in mean and standard deviation. The Student’s t-test and ANOVA were used. A p-
value of less than 0.05 (P<0.05) was considered statistically significant. 
 
3. Results 
The in between comparison in the subjects showed that the pretreatment subjects presented significantly higher 
mean total protein (g/dl), Globulin (g/dl), IgG (g/dl), IgM (g/dl) levels. However, the Albumin (g/dl) mean ±SD 
values was significantly lower in pretreatment compared with control subjects (P < 0.05). In the comparison 
between the groups; control and 2 months, 4 months, 6 months treatment (in each case), there were no significant 
difference observed [table 1]. The comparison between 2 months and 4 months, 6 months treatment (in each case) 
was significantly similar in mean parameters. Also 4 months treatment and 6 months treatment compared 
showed no significant different in mean parameters. The mean  ±SD comparison between variables in the 
pretreatment  and 2 months, 4 months, and 6 months treatment (in each case) showed statistically higher mean 
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levels at pretreatment in total protein(g/dl), Globulin(g/dl), IgG(g/dl), and IgM(g/dl) than the post treatment 
stages. However, the pretreatment subjects presented lower significant mean level of Albumin (g/dl) compared 
with the mean levels in 2 months , 4 months and 6 months (in each case) post treatment (P<0.05). The 
comparison of the parameters between the sex in the control subjects, pretreatment and all the post treatment 
stages shows no significant difference in all except IgG. IgG showed significantly higher value in female when 
pretreatment PTB only was compared.        
 
Table 1: Mean ± SD of Total Protein , Albumin , globulin , IgG  and 1gM  compared among control non 
pulmonary tuberculosis subjects (group A), pretreatment pulmonary tuberculosis patients (group B) and 
pulmonary tuberculosis patients in their 2 – month (group C), 4-month (group D) and 6-month (group E) 
treatment. 
Groups Total  
Protein (g/dl) 
Albumin (g/dl) Globulin (g/dl) IgG (g/dl) IgM (g/dl) 
A – Control (n=80) 7.16 3.96 3.21 989.10 134.21 
 
 
B – Pretreatment (n=100) 
±0.68 
 
9.26 
±0.22 
 
3.25 
±0.63 
 
5.83 
±241.72 
 
1841.80 
±48.05 
 
260.61 
 
 
C – 2-month treatment 
±0.77 
 
7.70 
±0.45 
 
3.95 
±1.05 
 
3.73 
±265.24 
 
1092.30 
±203.45 
 
144.59 
(n = 40) 
 
D – 4-month treatment 
±0.41 
 
7.47 
±0.21 
 
4.01 
±0.44 
 
3.42 
±186.94 
 
1053.10 
±45.65 
 
154.94 
(n = 40) 
 
E – 6-month treatment 
±0.50 
 
7.45 
±0.17 
 
4.02 
±0.62 
 
3.43 
±192.86 
 
1099.50 
±40.89 
 
152.36 
(n = 40) 
 
F(p)value 
±0.59 
 
142.65 
±0.20 
 
94.01 
±0.58 
 
168.11 
±226.14 
 
192.72 
±47.39 
 
15.05 
 (0.00) (0.00) (0.00) (0.00) (0.00) 
 
A vs B  p value 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
A vs C  p value 0.92 1.00 0.75 0.08 0.78 
A vs D  p value 0.05 0.67 0.45 0.52 0.11 
A vs E  p value 0.13 0.66 0.31 0.11 0.29 
B vs C  p value  0.00 0.00 0.00 0.00 0.00 
B vs D  p value 0.00 0.00 0.00 0.00 0.00 
B vs E   p value 0.00 0.00 0.00 0.00 0.00 
C vs D   p value 0.17 0.55 0.09 0.89 0.82 
C vs E   p value 0.21 0.54 0.09 1.00 0.95 
D vs E   p value 1.00 1.00 1.00 0.86 1.0 
Key = (p<0.05) 
 
4. Discussion 
In this present study, increased levels of total protein, globulin, 1gG and 1gM observed in pulmonary 
tuberculosis participants were corrected after 2 months of treatment with anti-tuberculosis drugs (Isoniazid, 
Ethambutol and Rifampcin). The present study showed also that reduced level of albumin observed in 
pretreatment pulmonary tuberculosis patients was corrected after 2 months of treatment with anti tuberculosis 
drugs. This report however contradicts earlier reports of decreased concentrations of 1gM in pulmonary 
tuberculosis patients (Grange et al, 2007). The present study correlates with earlier report of increased levels of 
total protein, globulin and decreased levels of albumin in PTB patients (Ferrara 2006, Daniel & Baum 2008). 
The increase in total protein in pre-treatment PTB patients correlates with the works of Ferrara (2006). The 
return of total protein level to normal is a good indication of disease control in that they correlate with sputum 
conversion to acid-fast bacilli negative. The increase in globulin level seen in pretreatment PTB patients 
correlates with ealier works by Gornall et al, (1949). Serum proteins abnormalities are related to factor such as 
fever with respect to Albumin and Globulin (Ferrara 2006). Immunoglobulin G was significantly higher in pre-
treatment PTB patients when compared with control non PTB subjects, 2 months treatment PTB patients, 4 
months treatment PTB patients and 6 months treatment PTB patients. This report correlates with the earlier 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.24, 2014 
 
40 
reports (Bradley et al, 2003). Immunoglobulum M was also significantly higher in pre-treatment PTB patients 
when compared with control non PTB subjects, 2 months treatment PTB patients, 4 months treatment PTB 
patients and 6 months treatment PTB patients. This report however contradicts the earlier reports of decreased 
titres of IgM in pre-treatment PTB patients (Grange et al, 2007). It has been shown in previous studies that a 
high proportion of patients with PTB has significantly increased levels of antibody to Mycobacterium 
tuberculosis (Geisberger et al, 2006, Alarcon-Sergovia & Fishbein 2003). Increase in IgG and IgM are therefore 
due to humoral response to mycobacterial antigen (Daniel & Baum 2008). Increase in IgM may probably also be 
due to secondary  superadded bacterial and fungal infections that these patients are so prone to develop. 
 
5. Conclusion 
In conclusion, the present study showed increase total protein, globulin, 1gG and 1gM in pulmonary tuberculosis 
infected patients. The study also indicates that serum concentration of these parameters returned to normal as 
patients undergo treatment. Based on these findings it is recommended that baseline levels of these parameters 
are obtained prior to treatment in order to monitor the progress of treatment in pulmonary tuberculosis patients. 
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